Recipharm's new blow-fill-seal machinery is now operational. The total number of lines to eight increases the facility’s manufacturing capacity by 200 million unidoses/year.

The Kaysersberg site is a facility specialising in Blow-fill-seal technology for sterile liquids. The site manufactures single dose units and has an advanced aseptic process for sterile liquid packaging applications.

In addition, the investment adds 2,400 m2 to the facility creating space for a further three machines, which will ultimately allow the site to manufacture more than 1.2 billion unidoses/year.

General Manager at Recipharm’s Kaysersberg site, said : “this latest investment is in direct response to customer demand for single-dose and sterile manufacturing services, such as aseptic processing for eye care and ear care products, particularly from markets such as the US, Turkey, Australia and Canada. This project was supported by the Region Grand Est and the CCI Alsace Eurométropole as part of employment-related actions”.

“Recipharm has only owned the facility for 2 years and during that time have taken some very fast and positive decisions to invest in Kaysersberg" said the direction.

All rights reserved except agreement written by Emballage Digest or mention of the magazine